Clinical Trial

Effect of Balloon Angioplasty vs Stenting Following Residual Stenosis After Endovascular Treatment of Intracranial Atherosclerotic Acute Ischemic Stroke

Study acronym: ANGEL-ICAS
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to evaluate whether rescue balloon angioplasty versus stenting for residual stenosis following endovascular therapy improves neurological outcomes in patients with acute large vessel occlusion due to large-artery atherosclerosis. Patients will be randomized into two groups: the balloon angioplasty group receiving balloon treatment alone followed by standard medical therapy, and the stent group receiving stenting treatment with post-procedural standard medical therapy. The primary efficacy endpoint is the proportion of patients achieving functional independence (modified Rankin Scale 0-2) at 90±7 days, while the safety endpoint is the probability of symptomatic intracranial hemorrhage occurring within 48 hours after randomization.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-17.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-08-12
Trial Details
NCT Number NCT07026331
Lead Sponsor Beijing Anzhen Hospital
Conditions Acute Ischemic Stroke
Enrollment 322 participants
Start Date 2025-07-03
Primary Completion 2027-04-01 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-13